Wilmot Cancer Institute is a clinical research site located in Rochester, New York, United States 14642.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Wilmot Cancer Institute has participated in 12 clinical trials with 6 currently active.
Therapeutic areas: Cancer, Prostate Cancer, Hematological Disease.
Sponsors: University of Rochester, Danielle Wallace, Eli Lilly and Company.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Wilmot Cancer Institute has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Wilmot Cancer Institute has 12 clinical trials on record, with 6 currently active. Their work covers Cancer, Prostate Cancer, Hematological Disease.
Yes — Wilmot Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.